Ionis Director, Global HEOR, Rare Disease Immunology, Successfully Placed by The Chase Group

Ionis Director, Global HEOR, Rare Disease Immunology, Successfully Placed by The Chase Group

Ami Claxton, MS, PhD has joined Ionis Pharmaceuticals, Inc. as Director, Global HEOR Rare Disease Immunology. She will play a critical and significant role as the commercial function grows with the launch of one of the rare disease assets currently in Phase III. Ami joins Montserrat Vera-Llonch’s team and will lead development of global HEOR research strategies and plans. The Chase Group wishes Ami much success in this strategic role! To learn more, email moira@chasegroup.com